These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 31182086)

  • 41. Oncovascular compartmental resection for retroperitoneal soft tissue sarcoma with vascular involvement.
    Bertrand MM; Carrère S; Delmond L; Mehta S; Rouanet P; Canaud L; Alric P; Quénet F
    J Vasc Surg; 2016 Oct; 64(4):1033-41. PubMed ID: 27374069
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term results of two prospective trials of preoperative external beam radiotherapy for localized intermediate- or high-grade retroperitoneal soft tissue sarcoma.
    Pawlik TM; Pisters PW; Mikula L; Feig BW; Hunt KK; Cormier JN; Ballo MT; Catton CN; Jones JJ; O'Sullivan B; Pollock RE; Swallow CJ
    Ann Surg Oncol; 2006 Apr; 13(4):508-17. PubMed ID: 16491338
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-term outcomes following resection of retroperitoneal recurrence of colorectal cancer.
    Razik R; Zih FS; Haase E; Mathieson A; Sandhu L; Cummings B; Lindsay T; Smith AJ; Swallow CJ
    Eur J Surg Oncol; 2014 Jun; 40(6):739-46. PubMed ID: 24246611
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effectiveness of regional hyperthermia with chemotherapy for high-risk retroperitoneal and abdominal soft-tissue sarcoma after complete surgical resection: a subgroup analysis of a randomized phase-III multicenter study.
    Angele MK; Albertsmeier M; Prix NJ; Hohenberger P; Abdel-Rahman S; Dieterle N; Schmidt M; Mansmann U; Bruns CJ; Issels RD; Jauch KW; Lindner LH
    Ann Surg; 2014 Nov; 260(5):749-54; discussion 754-6. PubMed ID: 25379845
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-term prognosis of primary retroperitoneal soft tissue sarcoma.
    van Dalen T; Plooij JM; van Coevorden F; van Geel AN; Hoekstra HJ; Albus-Lutter Ch; Slootweg PJ; Hennipman A; Dutch Soft Tissue Sarcoma Group
    Eur J Surg Oncol; 2007 Mar; 33(2):234-8. PubMed ID: 17081725
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Outcomes of palliative-intent surgery in retroperitoneal sarcoma-Results from the US Sarcoma Collaborative.
    Thalji SZ; Tsai S; Gamblin TC; Clarke C; Christians K; Charlson J; Ethun CG; Poultsides G; Grignol VP; Roggin KK; Votanopoulos K; Fields RC; Abbott DE; Cardona K; Mogal H;
    J Surg Oncol; 2020 Jun; 121(7):1140-1147. PubMed ID: 32167587
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Surgery and postoperative radiation therapy in primary retroperitoneal sarcomas: experience of the cancer centre Alexis-Vautrin].
    Fuks D; Verhaeghe JL; Marchal F; Guillemin F; Beckendorf V; Peiffert D; Leroux A; Rios M; Troufléau P; Marchal C
    Cancer Radiother; 2012 May; 16(3):194-200. PubMed ID: 22387193
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of chemotherapy on survival in surgically resected retroperitoneal sarcoma.
    Miura JT; Charlson J; Gamblin TC; Eastwood D; Banerjee A; Johnston FM; Turaga KK
    Eur J Surg Oncol; 2015 Oct; 41(10):1386-92. PubMed ID: 26251340
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neoadjuvant radiotherapy followed by surgery compared with surgery alone in the treatment of retroperitoneal sarcoma: a population-based comparison.
    Turner BT; Hampton L; Schiller D; Mack LA; Robertson-More C; Li H; Quan ML; Bouchard-Fortier A
    Curr Oncol; 2019 Dec; 26(6):e766-e772. PubMed ID: 31896947
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Survival outcomes of surgery for retroperitoneal sarcomas: A systematic review and meta-analysis.
    Guo Q; Zhao J; Du X; Huang B
    PLoS One; 2022; 17(7):e0272044. PubMed ID: 35901187
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Outcomes of Elderly Patients Undergoing Curative Resection for Retroperitoneal Sarcomas: Analysis From the US Sarcoma Collaborative.
    Wilkinson KH; Ethun CG; Hembrook M; Bedi M; Charlson J; Mogal H; Tsai S; Christians K; Tran TB; Poultsides G; Grignol V; Howard JH; Tseng J; Roggin KK; Chouliaras K; Votanopoulos K; Cullinan D; Fields RC; Weber S; Gamblin TC; Cardona K; Clarke CN
    J Surg Res; 2019 Jan; 233():154-162. PubMed ID: 30502242
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Surgically Treated Retroperitoneal Sarcoma: A Population-based Competing Risks Analysis.
    Nazzani S; Preisser F; Bandini M; Marchioni M; Tian Z; Soulières D; Montanari E; Ratti D; Acquati P; Briganti A; Shariat SF; Abdollah F; Carmignani L; Karakiewicz PI
    Eur Urol Oncol; 2018 Sep; 1(4):346-351. PubMed ID: 31100257
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Multimodality local therapy for retroperitoneal sarcoma.
    Paryani NN; Zlotecki RA; Swanson EL; Morris CG; Grobmyer SR; Hochwald SN; Marcus RB; Indelicato DJ
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1128-34. PubMed ID: 21664065
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characteristics and Outcomes of Locally Recurrent Retroperitoneal Sarcoma After First Relapse in a Single Tertiary Asian Centre and Applicability of the
    Lim HJ; Wong R; Koh YS; Ho ZS; Ong CJ; Farid M; Teo CCM
    Front Oncol; 2021; 11():730292. PubMed ID: 34900680
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Postoperative Morbidity After Resection of Recurrent Retroperitoneal Sarcoma: A Report from the Transatlantic Australasian RPS Working Group (TARPSWG).
    Nessim C; Raut CP; Callegaro D; Barretta F; Miceli R; Fairweather M; Rutkowski P; Blay JY; Strauss D; Gonzalez R; Ahuja N; Grignani G; Quagliuolo V; Stoeckle E; De Paoli A; Pillarisetty VG; Swallow CJ; Bagaria SP; Canter RJ; Mullen JT; Schrage Y; Pennacchioli E; van Houdt W; Cardona K; Fiore M; Gronchi A; Lahat G
    Ann Surg Oncol; 2021 May; 28(5):2705-2714. PubMed ID: 33389288
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Adjuvant radiotherapy in retroperitoneal sarcomas. A Scandinavian Sarcoma Group study of 97 patients.
    Trovik LH; Ovrebo K; Almquist M; Haugland HK; Rissler P; Eide J; Engellau J; Monge OR; Nyhus AB; Elde IK; Jebsen NL
    Acta Oncol; 2014 Sep; 53(9):1165-72. PubMed ID: 25000415
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic factors for reoperation of recurrent retroperitoneal sarcoma: The role of clinicopathological factors other than histologic grade.
    Yang JY; Kong SH; Ahn HS; Lee HJ; Jeong SY; Ha J; Yang HK; Park KJ; Lee KU; Choe KJ
    J Surg Oncol; 2015 Feb; 111(2):165-72. PubMed ID: 25244418
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Recurrent retroperitoneal sarcoma: impact of biology and therapy on outcomes.
    Grobmyer SR; Wilson JP; Apel B; Knapik J; Bell WC; Kim T; Bland KI; Copeland EM; Hochwald SN; Heslin MJ
    J Am Coll Surg; 2010 May; 210(5):602-8, 608-10. PubMed ID: 20421013
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Primary and recurrent retroperitoneal soft tissue sarcoma: prognostic factors affecting survival.
    Chiappa A; Zbar AP; Bertani E; Biffi R; Luca F; Crotti C; Testori A; Lazzaro G; De Pas T; Pace U; Andreoni B
    J Surg Oncol; 2006 May; 93(6):456-63. PubMed ID: 16615149
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long-Term Outcome After Surgery for a Localized Retroperitoneal Soft Tissue Sarcoma in Elderly Patients: Results from a Retrospective, Single-Center Study.
    Sourrouille I; Macovei R; Faron M; Le Péchoux C; Mir O; Adam J; Dumont S; Terrier P; Le Cesne A; Honoré C
    Ann Surg Oncol; 2018 Aug; 25(8):2201-2208. PubMed ID: 29797115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.